CN1312085A - 一种治疗皮肤病的药 - Google Patents
一种治疗皮肤病的药 Download PDFInfo
- Publication number
- CN1312085A CN1312085A CN 00112737 CN00112737A CN1312085A CN 1312085 A CN1312085 A CN 1312085A CN 00112737 CN00112737 CN 00112737 CN 00112737 A CN00112737 A CN 00112737A CN 1312085 A CN1312085 A CN 1312085A
- Authority
- CN
- China
- Prior art keywords
- tinea
- skin
- examples
- medicine
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 23
- 208000017520 skin disease Diseases 0.000 title claims description 5
- 206010048768 Dermatosis Diseases 0.000 title description 4
- 241000132012 Atractylodes Species 0.000 claims abstract description 4
- 235000012907 honey Nutrition 0.000 claims abstract description 4
- 238000011282 treatment Methods 0.000 claims description 12
- 241000522620 Scorpio Species 0.000 claims description 4
- 241000031023 Amana edulis Species 0.000 claims description 3
- 244000056139 Brassica cretica Species 0.000 claims description 3
- 235000003351 Brassica cretica Nutrition 0.000 claims description 3
- 235000003343 Brassica rupestris Nutrition 0.000 claims description 3
- 241000258920 Chilopoda Species 0.000 claims description 3
- 241000931705 Cicada Species 0.000 claims description 3
- 244000111489 Gardenia augusta Species 0.000 claims description 3
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 3
- 241000245240 Lonicera Species 0.000 claims description 3
- 241000237502 Ostreidae Species 0.000 claims description 3
- 241000545442 Radix Species 0.000 claims description 3
- 241000405414 Rehmannia Species 0.000 claims description 3
- 240000001949 Taraxacum officinale Species 0.000 claims description 3
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 3
- 240000006688 Telosma cordata Species 0.000 claims description 3
- 235000017352 Telosma cordata Nutrition 0.000 claims description 3
- 241000271897 Viperidae Species 0.000 claims description 3
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims description 3
- 235000010460 mustard Nutrition 0.000 claims description 3
- 235000020636 oyster Nutrition 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims 1
- 208000002474 Tinea Diseases 0.000 abstract description 26
- 241000130764 Tinea Species 0.000 abstract description 18
- 201000004624 Dermatitis Diseases 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 10
- 208000003251 Pruritus Diseases 0.000 abstract description 9
- 201000004681 Psoriasis Diseases 0.000 abstract description 8
- 208000010668 atopic eczema Diseases 0.000 abstract description 8
- 206010005913 Body tinea Diseases 0.000 abstract description 6
- 241000721454 Pemphigus Species 0.000 abstract description 6
- 201000003875 tinea corporis Diseases 0.000 abstract description 6
- 201000010618 Tinea cruris Diseases 0.000 abstract description 5
- 201000004647 tinea pedis Diseases 0.000 abstract description 5
- 240000001972 Gardenia jasminoides Species 0.000 abstract 1
- 241000533849 Gleditsia Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 241000949456 Zanthoxylum Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000010903 husk Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 206010040943 Skin Ulcer Diseases 0.000 description 14
- 231100000019 skin ulcer Toxicity 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 230000001139 anti-pruritic effect Effects 0.000 description 5
- 239000003908 antipruritic agent Substances 0.000 description 5
- 244000045947 parasite Species 0.000 description 5
- 206010067197 Tinea manuum Diseases 0.000 description 4
- 210000002683 foot Anatomy 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 230000003211 malignant effect Effects 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 206010040882 skin lesion Diseases 0.000 description 4
- 231100000444 skin lesion Toxicity 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000002607 hemopoietic effect Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 2
- 206010037888 Rash pustular Diseases 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 229960004022 clotrimazole Drugs 0.000 description 2
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229960002509 miconazole Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001473 noxious effect Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 208000029561 pustule Diseases 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 description 1
- VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 description 1
- 241000271039 Agkistrodon Species 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010012504 Dermatophytosis Diseases 0.000 description 1
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000283956 Manis Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241001460074 Microsporum distortum Species 0.000 description 1
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000010195 Onychomycosis Diseases 0.000 description 1
- -1 PIKANGWANG Chemical compound 0.000 description 1
- 206010033474 Pain of skin Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 241000101040 Pityriasis Species 0.000 description 1
- 241001250596 Pleione Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000131808 Scolopendra Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 238000003723 Smelting Methods 0.000 description 1
- 208000007712 Tinea Versicolor Diseases 0.000 description 1
- 206010056131 Tinea versicolour Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- GXDALQBWZGODGZ-UHFFFAOYSA-N astemizole Chemical compound C1=CC(OC)=CC=C1CCN1CCC(NC=2N(C3=CC=CC=C3N=2)CC=2C=CC(F)=CC=2)CC1 GXDALQBWZGODGZ-UHFFFAOYSA-N 0.000 description 1
- 229960004754 astemizole Drugs 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 229960003913 econazole Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 description 1
- 229960002867 griseofulvin Drugs 0.000 description 1
- 229960004130 itraconazole Drugs 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 239000009490 scorpio Substances 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 201000005882 tinea unguium Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明是一种治疗皮肤病的药,它由下列原料的中药配以蜂蜜制成:皂角刺、梅片、山栀、川军、赤勺、川椒、白术、蒲公英、紫花地丁、炙芥穗、煅牡蛎、苦参、川山甲、当归、黄芪、生地、降凡、金银花、山慈菇、蝉蜕、雅连、蜈蚣、全蝎、白花蛇。本发明主治各种顽固疮癣,对湿疹、瘙痒症、天疱疮、银屑癣、手足癣、体癣、股癣有特效。
Description
本发明涉及治疗皮肤病的药,尤其是治疗湿疹,瘙痒症、天疱疮、银屑癣、手足癣、体癣与股癣病的药。
皮肤病是一种顽固病,较为常见,发病率高且形症俱备,病因和症状也十分复杂,往往给患者造成不同程度的痛苦,因而影响患者的身心健康,更因其诊辩难以掌握,治疗棘手而为医者苦恼。现代皮肤科对皮肤顽固疮癣的治疗目的在于:1)、缓解临床症状;2)、减少皮损、止痒、促进皮肤恢复;3)、改善皮肤功能防止疮癣复发;4)、防止疮癣漫延,传染及并发症。目前,市面上内服外用治皮肤病的药品种很多,但都不能改变皮肤疮癣的自然病程和完全预防疮癣的复发。如外用皮肤药:灭丝菌癣药水、克霉唑癣药水、达克宁软膏、皮康王软膏、复方土槿皮酊等,内服药如:血毒丸、湿毒清胶丸及血毒清胶丸等对皮肤顽癣无效,只是对一般的皮肤过敏有缓解。
据查新,“一种治疗皮肤痛的口服药”申请号:98121810.5,公开号:CN1214261A,该发明虽能治各种皮肤病,但它的组成成份与本发明的组成成份不一样。
本发明的目的在于克服上述药品之缺陷,而提供一种能从根本上根治各种顽固疮癣、抗炎消肿,且无抗药性的药。
本发明的目的是这样实现的:
本发明由下列重量份的原料药制成:皂角刺 8~15 梅片 1~2 山栀 12~15川军 3~6 赤芍 8~14 川椒 3~6白术 10~15 蒲公英 15~20 紫花地丁12~20炙芥穗 8~15 煅牡蛎 15~25 苦参 5~12川山甲 5~10 当归 12~18 黄芪 12~18生地 15~25 降凡 4~8 金银花 15~25山慈菇 10~15 蝉蜕 12~18 雅连 5~10蜈蚣 2~4 全蝎 8~12 白花蛇 20~30蜂蜜 220~358
本发明的配制方法是将上述24味中草药晒干后粉碎成细末,加入比例为1∶1的蜂蜜制成块或丸,每块(丸)重6g。
本发明是以中医药理论为指导,处方合理,所采用的中草药具有以下功效:
山栀、雅连:具有清热利湿、解毒、除烦疗湿疮;川军、赤芍:具有凉血泻火、祛瘀止痛,破坚积、攻痈疮;皂角刺、山慈菇:具有托毒排脓、活血消痈、散结主,疔肿;苦参:具有杀虫、止痒、燥湿、疗恶疮疥癣;川山甲:具有通络通窍、杀虫、治恶疮、疥癣;当归、黄芪:具有活血、生血、和血、润筋骨皮肤,托毒生肌主痈疽久败毒疮为疮家圣药,取其“治风先治血,血行风自灭”之理;降凡、川椒:具有杀虫、解郁结、专治疮毒疥癣;蜈蚣、全蝎:能以毒攻毒,既能解毒散结,又能通络止痛,治疮疡肿毒瘰疬结核;白花蛇:具有行而不燥,搜风止痒,活络善治顽癣顽疮皮肤瘙痒;煅牡蛎:软坚散结,收敛消瘿疾,积块;金银花:解温疫秽恶、浊邪及扬梅诸恶疮;蝉蜕:巯风热止皮肤发痒及疔肿毒疮;梅片:能辟一切邪恶、散皮肤风湿。诸药配伍,严谨合理,称之为阴虚能补,血热能清,燥则能润,风则能祛,湿则能除,虫则能杀,痒则能止,瘀则能消,痈则能散。其成驱风止痒,除湿解毒,清热杀虫,消痈散结,排脓止痛,散瘀和血、养血、生血之功。全药佐以蜂蜜润燥益气扶正,安五脏诸不足及调和百药而共凑治皮肤顽疾之功效。
本发明功能:驱风止痒、除湿清热、解毒杀虫、消痈散结、排脓止痛、散瘀和血、健脾养血、生血、消斑祛黑。
本发明主治:各种顽固疮癣,如顽癣有:颈癣、体癣、甲癣、蛇皮癣、手脚癣、梅毒癣、松皮癣、牛皮癣、扁平癣、腹脐癣、黑运癣、银屑癣、梅花癣、面部花斑癣等。顽疮有:杨梅疮、秃疮、瘰疠肿疮、脸面毒疮、头顶硬头疮、麻风疮、旋耳疮、羊胡疮、天疤疮、头子疮、膝疮、沙木脚杆烂癣疮及湿疹、过敏性寻麻疹、丘疹、斑疹等对全身皮肤红肿、疼痛血泡腐烂、黄水长流等重症。
下面是本发明的临床疗效情况:
1、病例与方法(临床资料)
1.1、一般资料:本组250例患者均是经临床,中医望、闻、问、切辩证和实验室菌素试验诊断,皮肤癣菌直接涂片检查、培养检查、病原体检查、细胞检查、皮肤试验确诊的湿疹、瘙痒症、天疱疮,银屑癣、体癣与股癣、手足癣。其中男130例,女120例,年龄9-68岁,平均年龄32岁。250例患者中湿疹97例,瘙痒症32例,天疱疮19例,银屑癣23例,手足癣38例,体癣与股癣41例。病程半月-20余年。
1.2、临床表现:所有患者均有不同程度的皮肤瘙痒,疼痛、灼热、抓疤、疤痕、血痂、皮肤颜色改变,脱色或色素沉着等皮肤损害及全身不适。部分病例皮肤鳞屑脱落,糜烂、溃疡、起脓疱、水泡、丘疹、斑疹,皮肤皲裂或萎缩,均以痛苦不堪忍受就诊。
1.3、就诊前用药情况:250例患者在服用本发明治疗前均多方治疗,大多长时间服用过地塞米松、扑尔敏、息斯敏、斯皮仁诺、湿毒清、血毒丸、灰黄霉素、制霉菌片或注射钙剂和外用达克宁霜、皮康王、克霉唑、灭丝菌、皮炎平等疗效不佳或无效而就诊。
1.4、疗效评定标准
有效:用药5天,临床症状减轻,部份症状消失;显效:临床症状明显减轻,大部份症状消失;临床痊愈:症状全部消失,患者无任何皮肤痒、疼及不适之感,停药2月,病情无复发,反弹;痊愈:临床症状全部消失(或经病原体检查、菌素直接镜检或培养证实),停药4月病情无复发,无反弹。无效:用药7天,临床症状无减轻,无改善。
1.5、治疗方法和剂量
250例患者中除12例系未成年人外均系成年人,成人患者均按每次一块(6g)每日3次,未成年者按每次半块(3g)每日3次,饭前或饭后半小时用温开水或蜂糖开水吞服或嚼服。治疗期间不再加服其它药物。
2、治疗结果
2.1 250例患者经2-6周治疗后,痊愈236例,治愈率达94.4%,显效12例,无效2例。其中:97例湿疹2周痊愈69例,显效28例,4-5周痊愈28例,总治愈率100%;32例瘙痒症患者2-4周全部治愈,冶愈率100%;天疱疮患者19例,1月内全部治愈;银屑癣23例中22例1-2月内全部治愈,1例因皮损严重并有兼症治疗无效转走;手足癣38例中经3-6周治疗,29例痊愈,9例显效,总有效率100%;体癣与股癣41例中经5周治疗后痊愈36例,显效4例,无效1例因有严重并发症转院。
2.2、皮肤瘙痒消失时间1-5天195例,5-10天53例。
2.3、皮肤灼热、疼痛、抓疤、麻木、全身不适消失时间1-7天163例,7-15天76例。
2.4、糜烂、银屑、血痂、溃疡、脓疱、水泡、皲裂、萎缩皮肤改善时间:3-7天192例,7-14天53例。
2.5、不良反应及毒副作用:250例患者服用本发明药后,无1例出现明显的不良反应,说明本发明无毒副作用。
下面对本发明的实施例作进一步阐述:原料药名称 实施例1(重量份) 实施例2(重量份) 实施例3(重量份)皂角刺 8 12 15梅片 1 2 2山栀 12 14 15川军 3 5 6赤勺 8 10 14川椒 3 5 6白术 10 12 15蒲公英 15 17 20紫花地丁 12 15 20炙芥穗 8 12 15煅牡蛎 15 20 25苦参 5 10 12川山甲 5 7 10当归 12 15 18黄芪 12 15 18生地 15 20 25降凡 4 6 8金银花 15 20 25山慈菇 10 13 15蝉蜕 12 15 18雅连 5 7 10蜈蚣 2 3 4全蝎 8 10 12白花蛇 20 25 30蜂蜜 220 280 358
将上述中草药分别晒干共粉碎成细末,加入蜂蜜制成块或丸,每丸重6g,密闭备用。
用法用量:成人一天服三次,一次一丸,小儿均可服用,九岁以下小儿一天服一小丸,分二次服完,一个月为一疗程。
服药期间忌:辛、辣、酒、腥、发物、刺激饮食。
注意:孕妇及肥胖病人忌服,有严重胃病者用蜂糖开水送服。
Claims (1)
- 一种治疗皮肤病的药,其特征在于它是由下列重量份的原料制成:皂角刺 8~15 梅片 1~2 山栀 12~15川军 36 赤芍 8~14 川椒 3~6白术 10~15 蒲公英 15~20 紫花地丁12~20炙芥穗 8~15 煅牡蛎 15~25 苦参 5~12川山甲 5~10 当归 12~18 黄芪 12~18生地 15~25 降凡 4~8 金银花 15~25山慈菇 10~15 蝉蜕 12~18 雅连 5~10蜈蚣 24 全蝎 8~12 白花蛇 20~30蜂蜜 220~358
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 00112737 CN1312085A (zh) | 2000-03-08 | 2000-03-08 | 一种治疗皮肤病的药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 00112737 CN1312085A (zh) | 2000-03-08 | 2000-03-08 | 一种治疗皮肤病的药 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1312085A true CN1312085A (zh) | 2001-09-12 |
Family
ID=4582576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 00112737 Pending CN1312085A (zh) | 2000-03-08 | 2000-03-08 | 一种治疗皮肤病的药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1312085A (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102210804A (zh) * | 2011-05-22 | 2011-10-12 | 杨晓陆 | 一种治疗银屑病的药物 |
CN103495074A (zh) * | 2013-08-26 | 2014-01-08 | 许其树 | 一种治疗秃疮的中药组合物 |
CN103638176A (zh) * | 2013-12-12 | 2014-03-19 | 苏振华 | 一种治疗湿疹的药物及其制备方法 |
CN104398724A (zh) * | 2014-10-28 | 2015-03-11 | 山东瑞康生命科技有限公司 | 一种治疗天疱疮的中药制剂的制备方法 |
CN105250488A (zh) * | 2015-11-15 | 2016-01-20 | 衡阳市金凤牲猪养殖专业合作社 | 防治猪皮肤病的药物及其制备方法 |
CN107739671A (zh) * | 2017-10-18 | 2018-02-27 | 洪雅县瓦屋山药业有限公司 | 一种雅连药皂及其制备方法 |
DE112007001091B4 (de) | 2006-04-29 | 2019-02-21 | Shen Zhen Bei Ke Lian Pharmaceutical Sci-Tech Co.,Ltd. | Pharmazeutische Formulierung in Form einer Salbe für die Behandlung von Tinea der Füße und Hände und Zubereitungsverfahren davon |
-
2000
- 2000-03-08 CN CN 00112737 patent/CN1312085A/zh active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE112007001091B4 (de) | 2006-04-29 | 2019-02-21 | Shen Zhen Bei Ke Lian Pharmaceutical Sci-Tech Co.,Ltd. | Pharmazeutische Formulierung in Form einer Salbe für die Behandlung von Tinea der Füße und Hände und Zubereitungsverfahren davon |
CN102210804A (zh) * | 2011-05-22 | 2011-10-12 | 杨晓陆 | 一种治疗银屑病的药物 |
CN103495074A (zh) * | 2013-08-26 | 2014-01-08 | 许其树 | 一种治疗秃疮的中药组合物 |
CN103638176A (zh) * | 2013-12-12 | 2014-03-19 | 苏振华 | 一种治疗湿疹的药物及其制备方法 |
CN104398724A (zh) * | 2014-10-28 | 2015-03-11 | 山东瑞康生命科技有限公司 | 一种治疗天疱疮的中药制剂的制备方法 |
CN105250488A (zh) * | 2015-11-15 | 2016-01-20 | 衡阳市金凤牲猪养殖专业合作社 | 防治猪皮肤病的药物及其制备方法 |
CN107739671A (zh) * | 2017-10-18 | 2018-02-27 | 洪雅县瓦屋山药业有限公司 | 一种雅连药皂及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100434107C (zh) | 治疗痤疮的汤剂 | |
KR20240102982A (ko) | 두드러기, 습진, 알레르기/변태반응체질 치료를 위한 중약제제 | |
CN101040990A (zh) | 一种内服治疗痛风的中药组合物 | |
CN102861287A (zh) | 一种治疗湿热下注淤血型糖尿病足的中药组合物及其制备方法 | |
CN103142938A (zh) | 一种治疗跌打损伤骨折的膏药 | |
CN1312085A (zh) | 一种治疗皮肤病的药 | |
CN102028901B (zh) | 一种治疗膝关节增生性滑膜炎的中药 | |
CN101036758A (zh) | 一种内服治疗慢性浅表性胃炎的中药组合物 | |
CN101041006A (zh) | 一种内服治疗冠心病的中药组合物 | |
CN102406870B (zh) | 一种治疗风湿痹痛的药物 | |
CN100546640C (zh) | 一种内服治疗乳腺增生的中药组合物 | |
CN103585414B (zh) | 一种治疗坐骨神经痛并骨质疏松症的药物组合物 | |
CN101940656A (zh) | 一种治疗骨质增生的药物 | |
CN101485844B (zh) | 一种治疗慢性胃炎的中药组合物 | |
CN1284593C (zh) | 一种治疗过敏性紫癜的药 | |
CN112043799A (zh) | 一种治疗痛风的口服药物及其制备方法 | |
CN1255143C (zh) | 一种中药外用药酒及其制备方法 | |
CN1261123C (zh) | 一种治疗巴氏囊肿、疖、疔、疮、痈的中药制剂 | |
CN105193912A (zh) | 一种治疗急性乳腺炎的中药组合物及其制备方法 | |
CN101040979A (zh) | 一种内服治疗腰椎间盘突出的中药组合物 | |
CN104800772A (zh) | 一种治疗气郁型冠心病的中药组合物及应用 | |
CN103070994B (zh) | 一种治疗颈椎腰椎病的膏药 | |
CN102114225A (zh) | 一种治疗糖尿病痛风的中药 | |
CN101129716A (zh) | 一种内服治疗银屑病的中药组合物 | |
CN1380082A (zh) | 治疗妇科慢性炎症的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |